Safety Alerts & Recalls

Search all Safety Alerts & Recalls

Latest Alerts

Paddock Laboratories, Inc. Recalls Single Lot of Moexipril Tablets 7.5mg
Paddock Laboratories, Inc.has recalled a single lot of Moexipril Tablets 7.5mg. Lot number 2012028142 has been recalled because this lot failed the manufacturer’s routine test that measures the tablets’ ability to dissolve. Moexipril is used in the treatment of high blood pressure. Moexipril is also sold under the brand name Univasc. No other lots, strengths, or brands of Moexipril were involved in this recall. To view the FDA notice about this recall, please visit: http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Event-Detail.cfm?action=detail&id=63354&w=10172012&lang=eng
Learn More

Sandoz Inc. Recalls Several Lots of Children's Cetirizine Chewable Tablets 5 mg
Sandoz Inc. is recalling several lots of Children's Cetirizine Chewable Tablets 5 mg. The following lot numbers are being recalled because samples from this lot did not pass the manufacturer's routine tests for impurities and by-products from chemical breakdown over time: BT2862, BT7986, BT7994, BW0652, CC1961, CA3437, and BW0665. Children's Cetirizine contains the active ingredient Cetirizine and is commonly used in the treatment of allergies. Cetirizine is also sold under the brand name Zyrtec. This recall alert only applies to the select lots of Children's Cetirizine HCl Chewable Tablets 5 mg. No other Cetirizine products were involved in this recall. To view the FDA notice about this recall, please visit: http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Event-Detail.cfm?action=detail&id=63224&w=10242012&lang=eng
Learn More

Receive Safety Alerts & Recalls by email or text message.

Register

Date Published Title Drug Source
2012-10-30 Paddock Laboratories, Inc. Recalls Single Lot of Moexipril Tablets 7.5mg Moexipril FDA
2012-10-30 Sandoz Inc. Recalls Several Lots of Children's Cetirizine Chewable Tablets 5 mg Cetirizine FDA
2012-10-25 Keep Eye Drops and Nasal Sprays Out of Kids' Reach Tetrahydrozoline FDA
2012-10-17 FDA Advises Doctors to Contact Patients Who Were Given Any Injectable Medicine Made by NECC after May 21, 2012 Dorzolamide Hydrochloride with Timolol Maleate FDA
2012-10-11 FDA Update: Budeprion XL 300 mg Not Equivalent to Wellbutrin XL 300 mg Bupropion FDA
2012-10-08 Nephron Pharmaceuticals Corporation Recalls Select Lots of Albuterol Sulfate Inhalation Solution, 0.083%, 2.5 mg/3 mL Vials Albuterol FDA
2012-10-08 Apotex Corp Recalls Single Lot of Meloxicam Tablets, 15 mg Meloxicam FDA
2012-10-08 Teva Recalls Single Lot of Copaxone (glatiramer acetate injection), 20mg/mL Glatiramer Acetate FDA
2012-10-08 Hill Dermaceuticals Inc Recalls Several Lots of Derma-Smoothe/FS 0.01% Topical Oil (Scalp Oil) and Body Oil FDA
2012-10-07 FDA and CDC: Meningitis Outbreak Linked to Epidural Steroid Injection Methylprednisolone FDA
2012-10-02 Sandoz Inc. Recalls Several Lots of Pramipexole Tablets, 0.125 and 0.25 mg Pramipexole FDA
2012-10-02 Apace KY LLC Recalls Single Lot of Enalapril 5mg Tablets Enalapril FDA
2012-10-01 Patients Will Need to Make the Switch From Suboxone Tablets to Suboxone Sublingual Film Buprenorphine with Naloxone Manufacturer
2012-10-01 FDA Approves REMS Program For Mycophenolate-Containing Medicines to Reduce the Risks for Women Who Can Become Pregnant Mycophenolic Acid FDA
2012-09-25 Watson Laboratories Recalls Oversized Hydrocodone Bitartrate and APAP Tablets, 10 mg/500 mg Hydrocodone with Acetaminophen FDA
2012-09-21 Prometheus Laboratories Inc. Recalls Several Lots of Mercaptopurine Tablets 50 mg Mercaptopurine FDA
2012-09-20 FDA Is Conducting Ongoing Safety Review of Parkinson’s drug Mirapex (pramipexole) and Possible Risk of Heart Failure Pramipexole FDA
2012-09-17 Apotex Inc. Recalls Several Lots of Azelastine HCl Nasal Solution Azelastine FDA
2012-09-17 Galderma Laboratories Recalls Several Lots of Capex Shampoo FDA
2012-09-17 GlaxoSmithKline Recalls Several Lots of Ventolin HFA Inhaler Albuterol FDA
Back to Consumer Med Safety